BioSpace News Archive

Business

Biologics, Inc. Joins MedImpact Direct Specialty Program’s Specialty Pharmacy Network

Biologics, Inc, a McKesson Specialty Health oncology and complex care pharmacy services company, is now contracted with MedImpact Healthcare Systems, Inc. (“MedImpact”) to dispense specialty prescriptions under the MedImpact Direct Specialty program.

January 25, 2018
·
3 min read
Policy

Mariner Endosurgery Receives Health Canada Investigational Testing Approval for LaparoGuard Technology

Dr. Niv Sne, trauma surgeon proficient in advanced laparoscopic cases with Hamilton Health Sciences and Associate Professor of Surgery at McMaster University is the principal investigator for the initial studies.

January 25, 2018
·
1 min read
Biotech Bay

Achaogen Announces New Employment Inducement Grants - Jan. 25, 2018

The compensation committee of the Company’s board of directors granted six new employees the option to purchase an aggregate of 30,000 shares of the Company’s common stock and 15,001 restricted stock units.

January 25, 2018
·
1 min read
Synthon’s [vic-]Trastuzumab Duocarmazine (SYD985) Granted FDA Fast Track Designation For Pre-Treated HER2-Positive Metastatic Breast Cancer

This designation is for treating patients diagnosed with HER2-positive metastatic breast cancer (MBC) that has progressed during or after at least two HER2-targeting treatment regimens for locally advanced or metastatic disease, or progressed during or after [ado-]trastuzumab emtansine treatment.

January 25, 2018
·
6 min read
Business

Canon Medical Systems Partners with QED to Accelerate Development of New, Innovative MRI Technology

Canon Medical Systems USA, Inc., in partnership with Quality Electrodynamics (QED), installed a Vantage GalanTM 3T MR system at the new QED Research Center in Mayfield Village, Ohio.

January 25, 2018
·
2 min read
FDA

Synergy Pharmaceuticals Announces FDA Approval of TRULANCE (Plecanatide) for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Adults

Synergy Pharmaceuticals Inc. announced today that the FDA has approved TRULANCE (plecanatide) 3 mg tablet for the once-daily treatment of irritable bowel syndrome with constipation (IBS-C) in adults.

January 25, 2018
·
10 min read
Drug Development

The Medicines Company Release: Inclisiran’s First Pivotal Trial Achieves Target Enrollment Ahead of Schedule

The Medicines Company today announced that the target of 1,500 patients randomized in the ORION-11 trial has been exceeded in 11 weeks – considerably beating its goal of 28 weeks.

January 25, 2018
·
6 min read
Business

Celgene Reports Fourth Quarter and Full-Year 2017 Operating and Financial Results

For the fourth quarter of 2017, net product sales were $3,479 million, an increase of 17 percent, year-over-year.

January 25, 2018
·
33 min read
Business

Sobi Names Holly May Vice President of Sales and Marketing in United States

May will lead the commercial team in bringing Sobi’s multiple approved medicines to patients in the U.S.

January 25, 2018
·
3 min read
Biotech Beach

Penumbra Shows Off Real-World Study Data in Acute Ischemic Stroke Trial

The results were presented last night at the International Stroke Conference in Los Angeles.

January 25, 2018
·
6 min read